Stephanie Cox

1.7k total citations · 1 hit paper
41 papers, 914 citations indexed

About

Stephanie Cox is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Ophthalmology. According to data from OpenAlex, Stephanie Cox has authored 41 papers receiving a total of 914 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Public Health, Environmental and Occupational Health, 14 papers in Infectious Diseases and 10 papers in Ophthalmology. Recurrent topics in Stephanie Cox's work include Ocular Surface and Contact Lens (22 papers), HIV/AIDS drug development and treatment (14 papers) and HIV Research and Treatment (9 papers). Stephanie Cox is often cited by papers focused on Ocular Surface and Contact Lens (22 papers), HIV/AIDS drug development and treatment (14 papers) and HIV Research and Treatment (9 papers). Stephanie Cox collaborates with scholars based in United States, France and United Kingdom. Stephanie Cox's co-authors include Jason J. Nichols, Pedram Hamrah, James S. Wolffsohn, Fiona Stapleton, Nancy A. McNamara, Darlene A. Dartt, Jason J. Ivanusic, Mark I. Rosenblatt, Carolyn G. Begley and James A. Brock and has published in prestigious journals such as PLoS ONE, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Stephanie Cox

39 papers receiving 898 citations

Hit Papers

TFOS DEWS II pain and sensation report 2017 2026 2020 2023 2017 100 200 300 400

Peers

Stephanie Cox
Stephanie Cox
Citations per year, relative to Stephanie Cox Stephanie Cox (= 1×) peers Richard Yudi Hida

Countries citing papers authored by Stephanie Cox

Since Specialization
Citations

This map shows the geographic impact of Stephanie Cox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie Cox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie Cox more than expected).

Fields of papers citing papers by Stephanie Cox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephanie Cox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie Cox. The network helps show where Stephanie Cox may publish in the future.

Co-authorship network of co-authors of Stephanie Cox

This figure shows the co-authorship network connecting the top 25 collaborators of Stephanie Cox. A scholar is included among the top collaborators of Stephanie Cox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephanie Cox. Stephanie Cox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cox, Stephanie, Kristen Andreatta, Matthew R. Hendricks, et al.. (2025). Resistance Analyses of Lenacapavir, Emtricitabine/Tenofovir Alafenamide and Emtricitabine/Tenofovir Disoproxil Fumarate in the PURPOSE 1 and 2 Studies. The Journal of Infectious Diseases. 233(1). e203–e211.
2.
D’Antoni, Michelle L., et al.. (2025). Assessing phenotypic effect of integrase strand-transfer inhibitor (INSTI)-based resistance substitutions associated with failures on cabotegravir. Journal of Antimicrobial Chemotherapy. 80(4). 962–966. 2 indexed citations
3.
Cox, Stephanie, Nicolas Margot, & Christian Callebaut. (2023). Antiviral activity of tenofovir alafenamide (TAF) against HIV‐1 clinical isolates harboring K65R. Journal of Medical Virology. 95(4). e28723–e28723. 3 indexed citations
4.
Balbuena-Pareja, Ana, et al.. (2023). Effect of recombinant human nerve growth factor treatment on corneal nerve regeneration in patients with neurotrophic keratopathy. Frontiers in Neuroscience. 17. 1210179–1210179. 7 indexed citations
5.
Dieckmann, G., et al.. (2021). Low-dose naltrexone is effective and well-tolerated for modulating symptoms in patients with neuropathic corneal pain. The Ocular Surface. 20. 33–38. 29 indexed citations
6.
Cox, Stephanie, et al.. (2020). Dry Eye Disease Practice in Ghana: Diagnostic Perspectives, Treatment Modalities, and Challenges. Optometry and Vision Science. 97(3). 137–144. 6 indexed citations
7.
Huhn, Gregory, Moti Ramgopal, Mamta K. Jain, et al.. (2020). HIV/HCV therapy with ledipasvir/sofosbuvir after randomized switch to emtricitabine-tenofovir alafenamide-based single-tablet regimens. PLoS ONE. 15(1). e0224875–e0224875. 5 indexed citations
8.
Özmen, Mehmet Cüneyt, et al.. (2020). Efficacy and tolerability of nortriptyline in the management of neuropathic corneal pain. The Ocular Surface. 18(4). 814–820. 25 indexed citations
9.
Bekerman, Elena, Stephanie Cox, Darius Babusis, et al.. (2020). Two-dose emtricitabine/tenofovir alafenamide plus bictegravir prophylaxis protects macaques against SHIV infection. Journal of Antimicrobial Chemotherapy. 76(3). 692–698. 13 indexed citations
10.
Dieckmann, G., Yashar Seyed‐Razavi, Arsia Jamali, et al.. (2019). Structural and Functional Corneal Nerve Abnormalities suggest the Neurosensory Origin of Contact Lens Discomfort. Investigative Ophthalmology & Visual Science. 60(9). 3889–3889. 1 indexed citations
11.
Seyed‐Razavi, Yashar, G. Dieckmann, Arsia Jamali, et al.. (2019). Sensory Corneal Nerve Function Testing and Morphological Corneal Nerve Alterations Demonstrate Neurosensory Abnormalities and May Allow for Identification of Patients at Risk of Symptom Development. Investigative Ophthalmology & Visual Science. 60(9). 4733–4733. 2 indexed citations
12.
Dieckmann, G., Yashar Seyed‐Razavi, Arsia Jamali, et al.. (2019). Patients with Clinical Signs of Dry Eye Disease Demonstrate Presence of Signs of Neuropathic Corneal Pain. Investigative Ophthalmology & Visual Science. 60(9). 4199–4199. 2 indexed citations
13.
Cox, Stephanie, et al.. (2019). Effect of the Bruder moist heat eye compress on contact lens discomfort in contact lens wearers: An open-label randomized clinical trial. Contact Lens and Anterior Eye. 42(6). 625–632. 19 indexed citations
14.
Özmen, Mehmet Cüneyt, et al.. (2019). Nortriptyline is Effective in Ameliorating Symptoms of Neuropathic Corneal Pain. Investigative Ophthalmology & Visual Science. 60(9). 4732–4732. 5 indexed citations
15.
Cox, Stephanie, Nicolas Margot, Michael D. Miller, & Christian Callebaut. (2018). Antiviral Activity of Tenofovir Alafenamide Against HIV-1 Subtypes and Emergence of K65R. AIDS Research and Human Retroviruses. 34(5). 456–458. 2 indexed citations
16.
Margot, Nicolas, Stephanie Cox, Moupali Das, et al.. (2018). Rare emergence of drug resistance in HIV-1 treatment-naïve patients receiving elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide for 144 weeks. Journal of Clinical Virology. 103. 37–42. 16 indexed citations
17.
Berntsen, David A., et al.. (2018). A Randomized Trial to Evaluate the Effect of Toric Versus Spherical Contact Lenses on Vision and Eyestrain. Eye & Contact Lens Science & Clinical Practice. 45(1). 28–33. 7 indexed citations
18.
Cox, Stephanie, et al.. (2017). Evolution of tenofovir-resistant HIV-1 isolates exposed to tenofovir alafenamide dose escalation. Antiviral Research. 143. 22–29. 4 indexed citations
19.
Cox, Stephanie, David A. Berntsen, Sheila Hickson-Curran, et al.. (2016). Eyelid Margin and Meibomian Gland Characteristics and Symptoms in Lens Wearers. Optometry and Vision Science. 93(8). 901–908. 18 indexed citations
20.
Cox, Stephanie & Jason J. Nichols. (2014). The Neurobiology of the Meibomian Glands. The Ocular Surface. 12(3). 167–177. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026